Real Life Experience With Caduet [amlodipine/atorvastatin] Evaluating Effectiveness, Safety And Tolerability In The Management Of Cardiovascular Risk Factors (EXCEL Study)
Phase of Trial: Phase IV
Latest Information Update: 24 Jun 2009
At a glance
- Drugs Amlodipine/atorvastatin (Primary)
- Indications Dyslipidaemias; Hypertension
- Focus Therapeutic Use
- Acronyms EXCEL
- Sponsors Pfizer
- 24 Jun 2009 Actual initiation date changed from Jan 2008 to Dec 2007, patient number chnaged from 143 to 112 as reported by ClinicalTrials.gov.
- 24 Jun 2009 Primary endpoint changed to systolic and diastolic blood pressure as reported by ClinicalTrials.gov.
- 05 May 2008 Status changed from initiated to discontinued and actual patient numbers updated as reported by ClinicalTrials.gov